Pulse Oximeter Saturation Targeting and Oximeter Changes in the Benefits of Oxygen Saturation Targeting (BOOST)-II Australia and BOOST-II UK Oxygen Trials

Benjamin Stenson, Mark Donoghoe, Peter Brocklehurst , Peter Davis, Edmund Juszczak, Ian Marschner, John Simes, William Tanow-Mordi

Research output: Contribution to journalArticlepeer-review

Abstract

Infants in the Australian and UK BOOST-II trials using revised oximeters spent more time within their planned SpO2 target ranges than infants using the original oximeters (P<0.001). This may explain the larger mortality difference seen with revised oximeters. If so, average treatment effects from the NeoPrOM trials may be underestimates.
Original languageEnglish
JournalThe Journal of pediatrics
DOIs
Publication statusPublished - 9 Oct 2018

Fingerprint

Dive into the research topics of 'Pulse Oximeter Saturation Targeting and Oximeter Changes in the Benefits of Oxygen Saturation Targeting (BOOST)-II Australia and BOOST-II UK Oxygen Trials'. Together they form a unique fingerprint.

Cite this